Medvi addresses claims of fake doctors and patients following New York Times report

AI drug marketer Medvi responded to allegations of fake doctors and patients after a New York Times profile. The company claims an affiliate, not Medvi itself, violated FDA guidelines. Medvi states it was unaware of fake doctor advertisements until recently and has since updated marketing practices. The company also claims the FDA warning was directed at an affiliate's website, medvi.io, not its primary address, medvi.org. The company's response comes amid criticism for its use of AI-generated images and marketing practices, which have drawn scrutiny from regulatory bodies and media outlets.